These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. Egan TD; Minto CF; Hermann DJ; Barr J; Muir KT; Shafer SL Anesthesiology; 1996 Apr; 84(4):821-33. PubMed ID: 8638836 [TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Egan TD; Lemmens HJ; Fiset P; Hermann DJ; Muir KT; Stanski DR; Shafer SL Anesthesiology; 1993 Nov; 79(5):881-92. PubMed ID: 7902032 [TBL] [Abstract][Full Text] [Related]
4. Predictive performance of the 'Minto' remifentanil pharmacokinetic parameter set in morbidly obese patients ensuing from a new method for calculating lean body mass. La Colla L; Albertin A; La Colla G; Porta A; Aldegheri G; Di Candia D; Gigli F Clin Pharmacokinet; 2010; 49(2):131-9. PubMed ID: 20067337 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures. Ross AK; Davis PJ; Dear Gd GL; Ginsberg B; McGowan FX; Stiller RD; Henson LG; Huffman C; Muir KT Anesth Analg; 2001 Dec; 93(6):1393-401, table of contents. PubMed ID: 11726413 [TBL] [Abstract][Full Text] [Related]
6. Accuracy of pharmacokinetic models for predicting plasma fentanyl concentrations in lean and obese surgical patients: derivation of dosing weight ("pharmacokinetic mass"). Shibutani K; Inchiosa MA; Sawada K; Bairamian M Anesthesiology; 2004 Sep; 101(3):603-13. PubMed ID: 15329584 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application. Minto CF; Schnider TW; Shafer SL Anesthesiology; 1997 Jan; 86(1):24-33. PubMed ID: 9009936 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of remifentanil (GI87084B) and its major metabolite (GI90291) in patients undergoing elective inpatient surgery. Westmoreland CL; Hoke JF; Sebel PS; Hug CC; Muir KT Anesthesiology; 1993 Nov; 79(5):893-903. PubMed ID: 7902033 [TBL] [Abstract][Full Text] [Related]
9. Population pharmacodynamics and pharmacokinetics of remifentanil as a supplement to nitrous oxide anesthesia for elective abdominal surgery. Drover DR; Lemmens HJ Anesthesiology; 1998 Oct; 89(4):869-77. PubMed ID: 9778004 [TBL] [Abstract][Full Text] [Related]
10. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Minto CF; Schnider TW; Egan TD; Youngs E; Lemmens HJ; Gambus PL; Billard V; Hoke JF; Moore KH; Hermann DJ; Muir KT; Mandema JW; Shafer SL Anesthesiology; 1997 Jan; 86(1):10-23. PubMed ID: 9009935 [TBL] [Abstract][Full Text] [Related]
11. Population Pharmacokinetic Modeling of Remifentanil in Infants with Unrepaired Tetralogy of Fallot. Chang J; Shen Y; Huang Y; Sun Y; Cai MH; Niu J; Zhang LM; Zheng JJ; Zhang MZ Eur J Drug Metab Pharmacokinet; 2019 Feb; 44(1):53-62. PubMed ID: 29915955 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers. Hoke JF; Shlugman D; Dershwitz M; Michałowski P; Malthouse-Dufore S; Connors PM; Martel D; Rosow CE; Muir KT; Rubin N; Glass PS Anesthesiology; 1997 Sep; 87(3):533-41. PubMed ID: 9316957 [TBL] [Abstract][Full Text] [Related]
13. Remifentanil by bolus injection: a safety, pharmacokinetic, pharmacodynamic, and age effect investigation in human volunteers. Egan TD; Kern SE; Muir KT; White J Br J Anaesth; 2004 Mar; 92(3):335-43. PubMed ID: 14970134 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease. Dershwitz M; Hoke JF; Rosow CE; Michałowski P; Connors PM; Muir KT; Dienstag JL Anesthesiology; 1996 Apr; 84(4):812-20. PubMed ID: 8638835 [TBL] [Abstract][Full Text] [Related]
15. Influence of hemorrhagic shock on remifentanil: a pharmacokinetic and pharmacodynamic analysis. Johnson KB; Kern SE; Hamber EA; McJames SW; Kohnstamm KM; Egan TD Anesthesiology; 2001 Feb; 94(2):322-32. PubMed ID: 11176098 [TBL] [Abstract][Full Text] [Related]
16. Performance of propofol target-controlled infusion models in the obese: pharmacokinetic and pharmacodynamic analysis. Cortínez LI; De la Fuente N; Eleveld DJ; Oliveros A; Crovari F; Sepulveda P; Ibacache M; Solari S Anesth Analg; 2014 Aug; 119(2):302-310. PubMed ID: 24977639 [TBL] [Abstract][Full Text] [Related]
17. Feasibility of closed-loop co-administration of propofol and remifentanil guided by the bispectral index in obese patients: a prospective cohort comparison. Liu N; Lory C; Assenzo V; Cocard V; Chazot T; Le Guen M; Sessler DI; Journois D; Fischler M Br J Anaesth; 2015 Apr; 114(4):605-14. PubMed ID: 25500680 [TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics of remifentanil in patients undergoing orthotopic liver transplantation. Zhang LP; Yang L; Bi SS; Lu W; Zhang XH; Zhai SD; Duan LP Chin Med J (Engl); 2009 May; 122(9):1032-8. PubMed ID: 19493437 [TBL] [Abstract][Full Text] [Related]
19. Propofol clearance in morbidly obese children and adolescents: influence of age and body size. Diepstraten J; Chidambaran V; Sadhasivam S; Esslinger HR; Cox SL; Inge TH; Knibbe CA; Vinks AA Clin Pharmacokinet; 2012 Aug; 51(8):543-51. PubMed ID: 22690673 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic mass of fentanyl for postoperative analgesia in lean and obese patients. Shibutani K; Inchiosa MA; Sawada K; Bairamian M Br J Anaesth; 2005 Sep; 95(3):377-83. PubMed ID: 16024584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]